[18F]CTT1057

CTT1057 · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for [18F]CTT1057, covering 2024-12-18 to 2025-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of Diagnostic Performance of [18F]CTT1057 in BCR [Phase 3]